Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Gains from Investment Securities (2016 - 2025)

Ptc Therapeutics has reported Gains from Investment Securities over the past 14 years, most recently at $700000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $700000.0 for Q4 2025, up 106.82% from a year ago — trailing twelve months through Dec 2025 was -$6.6 million (down 453.87% YoY), and the annual figure for FY2025 was $173351.0, up 593.4%.
  • Gains from Investment Securities for Q4 2025 was $700000.0 at Ptc Therapeutics, up from -$100000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for PTCT hit a ceiling of $14.3 million in Q4 2023 and a floor of -$30.4 million in Q4 2022.
  • Median Gains from Investment Securities over the past 5 years was $700000.0 (2025), compared with a mean of -$398519.1.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 4415.38% in 2022 and later crashed 5448.62% in 2024.
  • Ptc Therapeutics' Gains from Investment Securities stood at $857693.0 in 2021, then tumbled by 3641.13% to -$30.4 million in 2022, then soared by 147.05% to $14.3 million in 2023, then tumbled by 171.81% to -$10.3 million in 2024, then surged by 106.82% to $700000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $700000.0 (Q4 2025), -$100000.0 (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.